MedTrace Logo

Misoprostol Versus Active Management of Labour in CS

NCT03390010 · Status: COMPLETED · Phase: PHASE1 · Type: INTERVENTIONAL · Enrollment: 300

Last updated 2022-11-16

No results posted yet for this study

Summary

Several treatment strategies are emplemented to prevent post delivery hemorage and decreasing maternal morbidity and mortality .

Conditions

  • Cesarean Section

Interventions

DRUG

Misoprostol + syntocinon and using extra uterotonic drugs when needed ; methergine

medical prophylaxis against postpartum atony and postpartum hemorage by giving misoprostol plus syntocinon and using extra uterotonic drugs when needed ; methergine, carboprost

DRUG

Syntocinon and using extra uterotonic drugs when needed ; methergine carboprost

medical prophylaxis against postpartum atony and postpartum hemorage by giving syntocinon and using extra uterotonic drugs when needed ; methergine, carboprost

Sponsors & Collaborators

  • Cairo University

    collaborator OTHER

  • Aljazeera Hospital

    lead OTHER

Principal Investigators

  • Mahmoud Alalfy, M.s.c · Algazeerah hospital -Location (Giza -Egypt )

  • yossra Lasheen, M.D · kasraliny hospital- Aljazeerah hospital

Study Design

Allocation
RANDOMIZED
Purpose
PREVENTION
Masking
DOUBLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
42 Years
Sex
FEMALE
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2017-12-28
Primary Completion
2018-02-28
Completion
2018-03-06

Countries

  • Egypt

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03390010 on ClinicalTrials.gov